Clinical Operations Manager

Job description
We are looking for a Clinical Operations Manager to join the team as our portfolio of novel TCR-modified T-cell therapies moves to clinical trials.
The role involves working within and alongside our clinical and translational teams on establishing, executing, and providing oversight of both non-interventional and interventional studies. We imagine that you have a few years of clinical research experience from biotech, small pharma or a CRO, and are looking for a role that will allow you to develop within an expanding organisation.


What we are looking for:
Experience of clinical trial planning and execution
Good knowledge of ICH-GCP
Good knowledge of relevant regulatory and ethical regulations, preferably including biobanking, with an emphasis on Sweden
Experience of submitting EC applications and of protocol and ICF development
Experience of developing site/CRO agreements
Experience of clinical vendor oversight
Goal orientated with a focus on proficiency and attention to detail
Ability to work efficiently both independently and in a team environment
Strong communication and leadership skills
Fluent in both English and Swedish, both written and oral



We offer: An international workplace, with plenty of variety in the job, interaction with all other Anocca employees and the opportunity to work at the exciting intersection of biotechnology and medicine.


Applicants should send a CV and detailed cover letter in English to jobs@anocca.com.
Please note that we contact candidates that we would like to invite for an interview within 3 weeks after the advertisement has closed. Unsuccessful candidates will not be contacted.


Anocca is a dynamic platform-based biotechnology company, based in modern labs in the Biovation Science Park in Södertälje. We are leading the way to a new generation of cancer therapies that harness the power of the immune system. We are a young group of more than 70 people from over 30 countries, and we are growing rapidly.
At Anocca we have developed a proprietary, innovative biological platform for high-throughput, systematic interrogation of the human immune system with high precision, which is first aimed at enabling treatment of cancers. With a range of novel capabilities, Anocca is continuing to deploy our proprietary technologies into new areas of research, while also focusing on bringing our first T-cell therapies for cancer to clinical trials using our own manufacturing capabilities.